FDA Draft Guidance: Considerations for Complying with 21 CFR 211.110
FDA's January 2025 draft on 21 CFR 211.110 outlines CGMP measures for batch uniformity, drug integrity, and advanced manufacturing innovation
Your trusted source for GMP excellence!